Trimetazidine MB treatment in patients with chronic heart failure

Trimetazidine MB treatment in patients with chronic heart failure

Aim. To assess the effects of the complex therapy, including trimetazidine MB, on the clinical course of chronic heart failure (CHF), cardiac hemodynamics, myocardial structure, function, and bio-electric activity in patients with coronary heart disease (CHD) complicated by CHF. Material and methods...

Full description

Bibliographic Details
Main Authors:	T. E. Morozova, E. I. Ivanova
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2010-06-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	coronary heart disease chronic heart failure cytoprotection trimetazidine
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/2084

Similar Items

THE USAGE OF TRIMETAZIDINE IN COMPLEX TREATMENT OF HEART FAILURE
by: N. R. Paleev, et al.
Published: (2001-04-01)

CYTOPROTECTION WITH TRIMETAZIDINE MB: RECENT DATA
by: I. G. Gordeev, et al.
Published: (2015-05-01)

Trimetazidine in chronic heart failure patients aged above 75 years
by: I. V. Ignatenko, et al.
Published: (1970-01-01)

RATIONALE FOR APPLICATION, AND BENEFITS OF TRIMETAZIDINE IN HEART FAILURE BY ITS INFLUENCE OF MYOCARDIUM METABOLISM
by: Yu. M. Lopatin, et al.
Published: (2016-08-01)

Trimetazidine MR effects on heart remodeling in stable coronary heart disease patients
by: E. M. Khurs, et al.
Published: (2007-02-01)

TRIMETAZIDINE INFLUENCE ON FILTRATION AND TUBULOINTERSTITIAL FUNCTION OF KIDNEYS IN ISCHEMIC HEART DISEASE PATIENTS WITH CHRONIC HEART FAILURE AND RENAL DYSFUNCTION
by: N. A. Koziolova, et al.
Published: (2018-03-01)

New potential of Trimetazidine MB for coronary heart disease treatment in the real-world clinical practice: results of the Russian multi-centre randomised study PERSPECTIVE (Part II)
by: M. G. Bubnova, et al.
Published: (2011-12-01)

ANTIISCHEMIC METABOLIC MODULATOR TRIMETAZIDINE IN TREATMENT OF CORONARY HEART DISEASE
by: V. P. Lupanov
Published: (2017-02-01)

Trimetazidine effects on heart and kidney functional status, and quality of life in long-term complex treatment of chronic heart failure in elderly patients
by: M. E. Statsenko, et al.
Published: (2005-10-01)

EFFECTS OF TRIMETAZIDINE ON THE TRANSMITRAL BLOOD FLOW IN PATIENTS WITH DIASTOLIC HEART FAILURE
by: Yu. N. Fedulaev, et al.
Published: (2015-09-01)

AN EXPERIENCE OF TRIMETAZIDINE USAGE IN COMORBIDITY
by: I. V. Kochetkova, et al.
Published: (2018-04-01)

THE PROBLEM OF INTERCHANGEABILITY OF DRUG PRODUCTS. TRIMETAZIDINE IS AN EFFECTIVE TREATMENT OF PATIENTS WITH ISCHEMIC HEART DISEASE
by: L. E. Chekuldaeva, et al.
Published: (2015-12-01)

INTERCHANGEABILITY OF MYOCARDIAL CYTOPROTECTORS IN PATIENTS WITH ISCHEMIC HEART DISEASE. DIFFICULT QUESTIONS –SIMPLE SOLUTIONS
by: Zh. M. Sizova
Published: (2015-09-01)

Pleiotropic effects of trimetazidine
by: O. V. Romashchenko, et al.
Published: (2013-08-01)

TRIMETAZIDINE MB ROLE IN THE OPTIMISATION OF THE ACUTE CORONARY SYNDROME TREATMENT: EFFECTS ON ENDOTHELIAL DYSFUNCTION AND SYSTEMIC INFLAMMATION
by: S. I. Davydov, et al.
Published: (2013-12-01)

CARDIOPROTECTION POTENTIAL IN CORONARY HEART DISEASE TREATMENT
by: N. A. Shostak, et al.
Published: (2009-12-01)

Clinical effectiveness of trimetazidine as a leading cardiovascular drug with metabolic action
by: A. Yu. Gasparyan, et al.
Published: (2008-08-01)

Trimetazidine in coronary heart disease patients: mechanism of action and controlled trials’ results
by: L. V. Kremneva, et al.
Published: (2005-04-01)

TRIMETAZIDINE THERAPY INFLUENCE ON HEART RATE VARIABILITY IN PATIENTS WITH STABLE ISCHEMIC HEART DISEASE
by: M. V. Novikova, et al.
Published: (2014-10-01)

Trimetazidine with an adjuvant therapy to normalize the circulating visfatin concentration: Future perspective and mechanistic strategies
by: G. Uma Maheswari, et al.
Published: (2023-12-01)

Anti-anginal and anti-ischemic effectiveness of trimetazidine MB in patients with unstable angina
by: M. G. Glezer, et al.
Published: (2009-02-01)

Pharmacoepidemiological analysis of therapy for chronic heart failure
by: D. D. Monakhova, et al.
Published: (2023-09-01)

Chronic heart failure in out-patient practice: aetiology issues
by: S. M. Bogdanova, et al.
Published: (2008-08-01)

Reactive oxygen species production by blood leukocytes and its correction by trimetazidine MB in patients with acute coronary syndrome
by: M. G. Glezer, et al.
Published: (2009-08-01)

Clinical effectiveness of long-term trimetazidine MB therapy in patients with cardio-respiratory disease (the results of an open, prospective multi-centre study)
by: N. M. Kolomoets, et al.
Published: (2009-12-01)

MYOCARDIAL DAMAGE BIOMARKERS DYNAMICS AFTER EXTRACARDIAC SURGERY IN CORONARY HEART DISEASE PATIENTS TAKING TRIMETAZIDINE MR
by: O. A. Bolshedvorskaya, et al.
Published: (2017-05-01)

Heart rate variability and hemostatic parameters in patients with coronary heart disease and chronic heart failure
by: M. Z. Buy, et al.
Published: (2013-10-01)

Clinical efficacy of nebivolol and metoprolol in complex treatment of patients with coronary heart disease and II-III functional class chronic heart failure
by: A. G. Evdokimova, et al.
Published: (2005-04-01)

MICROCIRCULATION IN CHRONIC HEART FAILURE PATIENTS TREATED WITH ACE INHIBITORS AND DIURETICS
by: Yu. I. Gurfinkel, et al.
Published: (2011-04-01)

STRUCTURAL AND FUNCTIONAL FEATURES OF LEFT VENTRICLE IN PATIENTS WITH HEART FAILURE, CORONARY HEART DISEASE AND THYROTOXICOSIS
by: E. V. PASHCHENKO, et al.
Published: (2018-10-01)

MANAGEMENT OF PATIENTS WITH RHEUMATIC HEART DISEASES AND CHRONIC HEART FAILURE
by: Aleksey Nikolayevich Kalyagin
Published: (2009-09-01)

Metabolic modulators in cardioprotection: A focus on trimetazidine
by: Du Qingyou
Published: (2024-01-01)

Combination of coronary heart disease, chronic heart failure, and anaemic syndrome: clinical features and prognostic impact of anaemia treatment
by: T. Yu. Kalyuta, et al.
Published: (2013-04-01)

EARLY DIAGNOSTICS OF HEART FAILURE IN PATIENTS WITH CORONARY HEART DISEASE
by: O. V. Bulashova, et al.
Published: (2003-08-01)

COMPARING MOLECULAR EFFECTS OF VARIOUS CYTOPROTECTORS IN COMPLEX THERAPY OF CORONARY HEART DISEASE
by: E. A. Kartashova
Published: (2009-10-01)

Study of Heart Rate Variability in Patients with Chronic Heart Failure and Chronic Obstructive Pulmonary Disease
by: M. E. Statsenko, et al.
Published: (2021-08-01)

TRIMETAZIDINE MR EFFECTS ON THE PARAMETERS OF 24-HOUR ELECTROCARDIOGRAM MONITORING AND HEART RATE VARIABILITY
by: M. V. Novikova, et al.
Published: (2013-10-01)

Prevention of chronic kidney disease progression in patients with acute decompensation of chronic heart failure
by: V. V. Davydov, et al.
Published: (2019-04-01)

Left and right ventricular diastolic dysfunction in patients with coronary heart disease and initial stages of chronic heart failure
by: Z. O. Georgadze, et al.
Published: (1970-01-01)

Diuretic therapy effects on the signal-averaged ECG parameters of atrial complex and supraventricular arrhythmias in patients with coronary heart disease and chronic heart failure
by: Kh. Kh. Shugushev, et al.
Published: (2011-12-01)